Duopharma Biotech Bhd (XKLS:7148) Margin of Safety % (DCF FCF Based): -48.15% (As of Jun. 26, 2026)


XKLS:7148 Duopharma Biotech Bhd XKLS:7148
82 GF Score
Price RM1.20
GF Value RM1.52
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Duopharma Biotech Bhd Margin of Safety % (DCF FCF Based)?

Duopharma Biotech Bhd XKLS:7148 82 Margin of Safety % (DCF FCF Based) is -48.15% as of Jun. 26, 2026. GuruFocus rates XKLS:7148 with a GF Score™ of 82/100 and a GF Value™ of RM1.52 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-26), Duopharma Biotech Bhd's Predictability Rank is 4-Stars. Duopharma Biotech Bhd's intrinsic value calculated from the Discounted FCF model is RM1.19 and current share price is RM1.20. Consequently,

Duopharma Biotech Bhd's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -48.15%.

XKLS:7148 vs ZTS, UTHR, VTRS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Duopharma Biotech Bhd Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's Margin of Safety % (DCF FCF Based) falls into.


XKLS:7148
82GF Score
Duopharma Biotech Bhd XKLS:7148
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Duopharma Biotech Bhd Margin of Safety % (DCF FCF Based) Calculation

Duopharma Biotech Bhd's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(0.81-1.20)/0.81
=-48.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

What does a Margin of Safety % (DCF FCF Based) of -48.15% mean?
Duopharma Biotech Bhd (XKLS:7148) has a Margin of Safety % (DCF FCF Based) of -48.15% as of Jun. 26, 2026. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on Duopharma Biotech Bhd.
Is Duopharma Biotech Bhd's Margin of Safety % (DCF FCF Based) too high?
Duopharma Biotech Bhd's current Margin of Safety % (DCF FCF Based) is -48.15%. Overall, Duopharma Biotech Bhd has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Duopharma Biotech Bhd's Margin of Safety % (DCF FCF Based) compare to ZTS and UTHR?
Duopharma Biotech Bhd's Margin of Safety % (DCF FCF Based) of -48.15% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF FCF Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF FCF Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF FCF Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF FCF Based) mean?
A high Margin of Safety % (DCF FCF Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on Duopharma Biotech Bhd. Duopharma Biotech Bhd's current Margin of Safety % (DCF FCF Based) is -48.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Duopharma Biotech Bhd stock overvalued right now?
Based on GuruFocus' analysis, Duopharma Biotech Bhd (XKLS:7148) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.52, compared to a current price of RM1.20 — trading 21.1% below its estimated fair value. The current Margin of Safety % (DCF FCF Based) is -48.15%. Duopharma Biotech Bhd's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF FCF Based) calculated?
Margin of Safety % (DCF FCF Based) is calculated from a company's financial statements. For Duopharma Biotech Bhd (XKLS:7148), the current Margin of Safety % (DCF FCF Based) is -48.15% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Duopharma Biotech Bhd (XKLS:7148) Overvalued in 2026?

Based on GuruFocus' analysis, Duopharma Biotech Bhd stock appears to be undervalued. The current stock price of RM1.20 is trading 21.1% below its estimated GF Value™ of RM1.52. GuruFocus considers Duopharma Biotech Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:7148:

  • Margin of Safety % (DCF FCF Based): -48.15%
  • GF Value™: RM1.52 vs. price of RM1.20 (21.1% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the XKLS:7148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Duopharma Biotech Bhd Business Description

Address Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. The company develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.
82GF Score

Get the complete analysis for XKLS:7148

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.20
Price
RM1.52
GF Value